3.09
4.39%
0.13
前日終値:
$2.96
開ける:
$2.96
24時間の取引高:
7.70M
Relative Volume:
1.80
時価総額:
$1.27B
収益:
$4.78B
当期純損益:
$-284.68M
株価収益率:
-4.4783
EPS:
-0.69
ネットキャッシュフロー:
$-184.84M
1週間 パフォーマンス:
+27.16%
1か月 パフォーマンス:
+54.50%
6か月 パフォーマンス:
-58.07%
1年 パフォーマンス:
-57.44%
Agilon Health Inc Stock (AGL) Company Profile
AGL を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
3.09 | 1.27B | 4.78B | -284.68M | -184.84M | -0.69 |
HCA
Hca Healthcare Inc
|
310.45 | 78.64B | 69.62B | 5.93B | 5.88B | 22.27 |
DVA
Davita Inc
|
166.24 | 14.58B | 12.67B | 827.68M | 1.42B | 9.27 |
FMS
Fresenius Medical Care Ag Adr
|
23.07 | 13.54B | 20.87B | 715.14M | 1.67B | 1.2209 |
THC
Tenet Healthcare Corp
|
130.86 | 12.78B | 20.97B | 3.13B | 2.39B | 31.21 |
UHS
Universal Health Services Inc
|
184.80 | 12.19B | 15.42B | 1.03B | 956.84M | 15.02 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-01-10 | アップグレード | Citigroup | Sell → Neutral |
2025-01-10 | 開始されました | Needham | Hold |
2024-12-16 | 開始されました | Macquarie | Neutral |
2024-12-11 | 開始されました | Bernstein | Mkt Perform |
2024-11-11 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
2024-11-08 | ダウングレード | William Blair | Outperform → Mkt Perform |
2024-10-30 | ダウングレード | Citigroup | Neutral → Sell |
2024-10-02 | ダウングレード | BofA Securities | Buy → Underperform |
2024-05-30 | 開始されました | Robert W. Baird | Neutral |
2024-04-22 | 開始されました | Citigroup | Neutral |
2024-03-06 | 開始されました | Barclays | Underweight |
2024-02-26 | ダウングレード | Jefferies | Buy → Hold |
2024-02-26 | ダウングレード | TD Cowen | Outperform → Market Perform |
2024-01-08 | ダウングレード | Leerink Partners | Outperform → Market Perform |
2024-01-08 | ダウングレード | Stifel | Buy → Hold |
2024-01-08 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
2024-01-05 | ダウングレード | JP Morgan | Overweight → Neutral |
2024-01-05 | ダウングレード | Truist | Buy → Hold |
2023-12-11 | ダウングレード | Goldman | Buy → Neutral |
2023-12-06 | 開始されました | JMP Securities | Mkt Outperform |
2023-11-21 | ダウングレード | Deutsche Bank | Buy → Hold |
2023-10-20 | 開始されました | The Benchmark Company | Buy |
2023-06-13 | 開始されました | Evercore ISI | In-line |
2022-12-09 | 開始されました | Stifel | Buy |
2022-09-14 | 開始されました | RBC Capital Mkts | Outperform |
2022-09-12 | 開始されました | Goldman | Buy |
2022-09-07 | 再開されました | Truist | Buy |
2022-06-24 | 開始されました | BTIG Research | Neutral |
2022-03-30 | 開始されました | Guggenheim | Buy |
2021-10-20 | 開始されました | Jefferies | Buy |
2021-09-27 | 開始されました | SVB Leerink | Outperform |
2021-09-10 | 開始されました | Cowen | Outperform |
2021-05-11 | 開始されました | William Blair | Outperform |
2021-05-10 | 開始されました | BofA Securities | Buy |
2021-05-10 | 開始されました | Deutsche Bank | Buy |
2021-05-10 | 開始されました | Goldman | Buy |
2021-05-10 | 開始されました | JP Morgan | Overweight |
2021-05-10 | 開始されました | Truist | Buy |
2021-05-10 | 開始されました | Wells Fargo | Overweight |
2021-05-10 | 開始されました | Wolfe Research | Outperform |
すべてを表示
Agilon Health Inc (AGL) 最新ニュース
agilon health validates InvestingPro's Fair Value analysis with 60% rally By Investing.com - Investing.com Canada
agilon health (NYSE:AGL) Trading Up 8.5% Following Analyst Upgrade - MarketBeat
Here’s Why Analysts Just Upgraded Agilon Health (AGL) - MSN
Market-Perform maintained for agilon health stock amid cash flow prudence - Investing.com India
Sanford C. Bernstein Forecasts Strong Price Appreciation for agilon health (NYSE:AGL) Stock - MarketBeat
Further Upside For agilon health, inc. (NYSE:AGL) Shares Could Introduce Price Risks After 29% Bounce - Simply Wall St
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday - Benzinga
Citi moves agilon health to Neutral rating, noting impact of favorable MA policies - Investing.com Australia
Citi moves agilon health to Neutral rating, noting impact of favorable MA policies By Investing.com - Investing.com South Africa
agilon health (NYSE:AGL) Trading Up 6.4%Time to Buy? - MarketBeat
Citigroup Upgrades agilon health (AGL) - MSN
Commit To Buy Agilon Health At $2, Earn 37.5% Using Options - Nasdaq
Agilon Health stock under scrutiny—margin recovery efforts yet to prove effective - Investing.com India
HIMS downgraded, agilon upgraded at Citi in 2025 Health Tech review - Seeking Alpha
Agilon Health stock under scrutiny—margin recovery efforts yet to prove effective By Investing.com - Investing.com South Africa
agilon health (NYSE:AGL) Earns Hold Rating from Analysts at Needham & Company LLC - MarketBeat
agilon health (NYSE:AGL) Shares Up 9.6%Here's What Happened - MarketBeat
Securities Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Western District of Texas against agilon health, inc. - AccessWire
Short Interest in agilon health, inc. (NYSE:AGL) Declines By 6.7% - MarketBeat
agilon health, inc. (NYSE:AGL) Position Cut by Stifel Financial Corp - Defense World
Agilon Health, Inc, B. Riley Financial, Target Corporation, - GlobeNewswire
Agilon Health, Inc, B. Riley Financial, Target Corporation, and Getty Images Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - GlobeNewswire Inc.
agilon health, inc. (NYSE:AGL) Receives $4.28 Consensus Target Price from Analysts - MarketBeat
agilon health (NYSE:AGL) Trading Down 5.8%Here's Why - MarketBeat
agilon health Slides As Insider Purchases Lose Another US$50k - Simply Wall St
agilon health (NYSE:AGL) Trading 5% HigherWhat's Next? - MarketBeat
AGILON HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of agilon health, inc.AGL - The Eastern Progress Online
agilon health (NYSE:AGL) Stock Price Down 7.8%Here's Why - MarketBeat
Forecasting The Future: 10 Analyst Projections For Agilon Health - Benzinga
agilon health, inc. (NYSE:AGL) Short Interest Update - MarketBeat
agilon health (NYSE:AGL) Now Covered by Analysts at Macquarie - MarketBeat
Macquarie starts agilon health at Neutral amid market challenges - Investing.com
Macquarie starts agilon health at Neutral amid market challenges By Investing.com - Investing.com South Africa
Agilon Health's SWOT analysis: stock faces challenges amid value-based care push - Investing.com
agilon health, inc. (NYSE:AGL) Director Purchases $55,000.00 in Stock - MarketBeat
Agilon Health director McLoughlin buys $55,084 in stock By Investing.com - Investing.com Canada
Agilon Health director McLoughlin buys $55,084 in stock - Investing.com India
Agilon Health director Silvana Battaglia acquires $50,269 in stock By Investing.com - Investing.com Australia
Agilon Health director Silvana Battaglia acquires $50,269 in stock - Investing.com
Bernstein Initiates Coverage of agilon health (AGL) with Market Perform Recommendation - MSN
Agilon health director Diana McKenzie buys $44,962 in common stock By Investing.com - Investing.com Nigeria
Agilon Health director Wulf John William buys $98,145 in stock By Investing.com - Investing.com Australia
Agilon Health director Wulf John William buys $98,145 in stock - Investing.com
Sanford C. Bernstein Initiates Coverage on agilon health (NYSE:AGL) - MarketBeat
Agilon Health Inc (AGL) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):